Join
Live feed
·
INSIDERFilingvia Quantisnow
Zymeworks Inc. logo

EVP & Chief Medical Officer Smith Jeffrey T L sold $211,090 worth of shares (9,310 units at $22.67) and converted options into 17,666 shares, increasing direct ownership by 46% to 26,708 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZYME (Zymeworks Inc.) and more on Quantisnow.